Prostate cancer
Prostate Cancer: A State of The Heart
... a prostate magnetic resonance imaging (MRI) scan showed a suspicious area of minimal extracapsular extension at the right ...apex. Prostate-speciic antigen (PSA) levels were ...
6
Mobile application-based Seoul National University Prostate Cancer Risk Calculator: development, validation, and comparative analysis with two Western risk calculators in Korean men.
... Patients and Methods: As a retrospective study, consecutive men who underwent initial prostate biopsy with more than 12 cores at a tertiary center were included. In the development stage, 3,482 cases from May 2003 ...
7
Optimal use of prostate specific antigen for prostate cancer screening
... 12. Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ, Yossepowitch O, Vickers AJ, et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate- specific ...
3
CXCR4 expression in prostate cancer progenitor cells.
... of prostate cancer ...in prostate cancer progenitors could lead to more effective cancer treatment and may provide synergistic antitumor activity with conventional ...of prostate ...
13
Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.
... affect prostate cancer susceptibility and the frequency of RASSF1A methylation was found to be significantly higher in patients’ group compared with control ...
8
Bimodal probes for imaging of prostate cancer
... Prostate cancer (PCa) is the most common malignancy found in men affecting one in six and is the second leading cause of cancer-related death in ...the prostate-specific membrane antigen ...
105
STRATEGIES FOR THE PREVENTION OF PROSTATE CANCER
... of prostate cancer and to describe strategies for the prevention of prostate ...of prostate cancer, Sociocultural difficulties for the prevention of prostate cancer and ...
13
Prostate cancer – Therapy with radium-223
... 12. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988; 318(26):1728-33. 13. U.S.NRC. Office of Nuclear Material Safety and Safeguards. ...
5
Differences in prostate cancer detection between Canadian and Saudi populations
... the cancer incidence was significantly lower in Saudi vs Canadian men among all age groups (0, 8, ...higher prostate cancer detection incidence upon biopsy, whereas in the KSUH cohort, ...
7
Cancer stem cells in prostate cancer: implications for targeted therapy
... Prostate cancer (PCa) is the most frequently diagnosed cancer in men and the second most common cause of cancer-related mortality among men in the developed ...cases, cancer therapies ...
12
Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells.
... cultured cancer cells spiked into blood from healthy donors may model the separation of these cells from hematological cells that differ in cell size but the common pre-treatment of these cells with trypsin, to ...
7
Editor’s Pick: PSMA-Specific Ligands in Prostate Cancer Diagnosis and Therapy
... Similarly, PSMA aptamers have been used in small interfering RNA (siRNA) delivery for prostate cancer therapy. Since the discovery of RNA interference, siRNAs have attracted much attention as novel ...
8
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
... Moreover, we investigated the potential predictors of finasteride concentrations and found that drug serum concentrations were significantly associated with age at baseline and alcohol consumption specifically more than ...
13
Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: a retrospective study in patients with advanced prostate cancer.
... Prostate cancer is a relatively benign disease and cancer specific survival estimates in organ confined prostate cancer are >95% at 10 years ...in cancer specific survival and ...
8
Bony-based and prostate-based image guidance for lo-calized prostate cancer radiotherapy
... circumferentially was used in both groups. Limiting factors of this study may be considered (a) the number of patients studied. Volumetric doses in the rectum were systematically lower when P-ISO was adopted. Perhaps a ...
18
Current concepts in multiparametric magnetic resonance imaging for active surveillance of prostate cancer
... p3+3, prostate-specific antigen (PSA) p10 ng/mL, clinical stage pT2, maximum of 2 positives cores or p50% per ...Sloan-Kettering Cancer Center who admitted patients with up to three involved cores and the ...
6
GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells
... Several other metabolites identified were also able to discriminate between different cancer cell lines and normal cell lines, namely L-alanine (PC3 versus PNT2, DU145 versus PNT2, and L[r] ...
15
Int. braz j urol. vol.29 número5
... Tissue micro-array studies also described other biomarkers for PCa, suggesting its role for searching for therapeutic targets and as prognostic factors. Loss or decreased expression detected by tissue micro-array of CD10 ...
11
Int. braz j urol. vol.34 número3
... of prostate cancer is usu- ally clinically suspected based on PSA kinetics and is usually characterized by a prolonged doubling time ! months) in a patient with a Gleason score of 2–7, a positive ...
3
Rev. LatinoAm. Enfermagem vol.19 número1
... The translation of the questions from international questionnaires was performed by a Brazilian researcher with a command of the English language. The content validity of the instrument was carried out by a researcher ...
8